Lambda Pharm sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-10-03
Share capital
10,000.00 PLN
Registered address
ul. Słoneczna 116A, 05-500 Stara Iwiczna, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 154 days for 2024).

  • 2025not filed
  • 202416/12/2025
  • 202303/12/2024
  • 202209/07/2023
  • 202128/09/2022
  • 202001/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 94%
Division · Retail trade11,131 / 13,332
Top 83%
Voivodeship · Mazowieckie102,891 / 142,258
Top 72%
Country · Poland368,148 / 496,593
Top 74%

Results vs industry

Revenue
This companyUSD 28.90kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 2.35kMedianUSD 21.19kAverageUSD 85.68k
Operating costs
This companyUSD 26.52kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 9.70kMedianUSD 545.00kAverageUSD 1.76m

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. 1 application is pending. 1 mark has expired or was not registered. The first mark was filed in 2019.

MarkNumberClassesStatusProtected until
Red Pharma Laboratories Z.5041633, 5Protected Sep 6, 2029
EFA Z.5959163Application pending –
EFA Z.5912763Proceedings discontinued –
MarkProtected until
Red Pharma Laboratories Sep 6, 2029
EFA –
EFA –

Authorized Representatives

Beata Prejsnar age 51 – President of the Management Board
Daniel Kużbiel age 34 – Vice President of the Management Board
Michał Paweł Sinczak age 54 – Management Board Member

Manner of representation

To submit declarations of will on behalf of the company, in the case of a multi-member management board, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required. In the case of a one-person management board, the President of the Management Board independently represents the company. In every case, the company may be represented by an appointed commercial proxy with sole power of representation.

Ownership

OwnerSharesShare valueStake
27$364.6713.5%
40$540.2520%
56$756.3528%
42$567.2621%
Others
35$472.7217.5%

Beneficial owners

Person

Subsidiaries

NameStake
40%

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2020-10-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
DR Zdrowie S.A.
Magmax S.A.
Adpharma sp. z o.o.
Novopharm - Miller sp. j.
Maglow S.A.
Farmacja Im. O. Klimuszki sp. z o.o.
Nuklover sp. z o.o.
Massmed sp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w Warszawie S.A.
Femaherb sp. z o.o.

Change history

DateEvent
2021-07-01Address change
2017-10-03Entered in the register

FAQ

Last updated: 2026-04-25